Monday, December 05, 2016

CBD / Cannabadiol reduces seizures in Dravet Syndrome

Side effects were frequently seen. Your epilepsy specialist should monitor effects on other anticonvulsants. - JR

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.
HOUSTON – Adjunctive treatment with cannabidiol reduces convulsive seizure frequency in patients with Dravet syndrome, according to results from a phase 3 study presented at the 2016 American Epilepsy Society Annual Meeting.
While efficacy has previously been demonstrated in this population in data reported from an expanded-access program, this is the first placebo-controlled trial examining the efficacy and safety of cannabidiol in refractory Dravet syndrome.

No comments: